Year |
Citation |
Score |
2011 |
Van Rite BD, Lazrak YA, Pagnon ML, Palwai NR, Neves LF, McFetridge PS, Harrison RG. Enzyme prodrug therapy designed to target L-methioninase to the tumor vasculature. Cancer Letters. 301: 177-84. PMID 21194833 DOI: 10.1016/J.Canlet.2010.11.013 |
0.393 |
|
2010 |
Neves LF, Tsai TW, Palwai NR, Martyn DE, Tan Y, Schmidtke DW, Resasco DE, Harrison RG. Non-covalent attachment of proteins to single-walled carbon nanotubes. Methods in Molecular Biology (Clifton, N.J.). 625: 3-8. PMID 20422376 DOI: 10.1007/978-1-60761-579-8_1 |
0.614 |
|
2009 |
Palwai NR, Zang XP, Harrison RG, Benbrook D, Pento JT. Selective growth inhibition of cancer cells by L-methioninase-containing fusion protein targeted to the urokinase receptor. Pharmacology. 84: 271-5. PMID 19797936 DOI: 10.1159/000242997 |
0.671 |
|
2007 |
Palwai NR, Zang XP, Harrison RG, Pento JT. Influence of L-methioninase targeted to the urokinase receptor on the proliferation and motility of lung and prostate cancer cells. Anticancer Research. 27: 3435-9. PMID 17970092 |
0.688 |
|
2007 |
Palwai NR, Martyn DE, Neves LFF, Tan Y, Resasco DE, Harrison RG. Retention of biological activity and near-infrared absorbance upon adsorption of horseradish peroxidase on single-walled carbon nanotubes Nanotechnology. 18. DOI: 10.1088/0957-4484/18/23/235601 |
0.511 |
|
2006 |
Zang XP, Palwai NR, Lerner MR, Brackett DJ, Pento JT, Harrison RG. Targeting a methioninase-containing fusion protein to breast cancer urokinase receptors inhibits growth and migration. Anticancer Research. 26: 1745-51. PMID 16827102 |
0.682 |
|
2006 |
Zang X, Palwai NR, Pento JT, Harrison RG. Internalizing Versus Non-internalizing Receptors for Targeting L-Methioninase to Cancer Cells American Journal of Pharmacology and Toxicology. 1: 60-64. DOI: 10.3844/Ajptsp.2006.60.64 |
0.661 |
|
2005 |
Palwai NR, Zang XP, Pento JT, Harrison RG. Targeting L-methioninase to human cancer cells Aiche Annual Meeting, Conference Proceedings. 9135-9136. |
0.498 |
|
Show low-probability matches. |